Platelet-to-Lymphocyte Ratio Predicts Survival Outcomes in Patients With Synchronous mRCC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Platelet-to-Lymphocyte Ratio as a Significant Prognostic Factor to Predict Survival Outcomes in Patients With Synchronous Metastatic Renal Cell Carcinoma
Investig Clin Urol 2020 Jul 23;[EPub Ahead of Print], HD Yuk, M Kang, EC Hwang, JY Park, CW Jeong, C Song, SI Seo, SS Byun, C Kwak, SH Hong, J Chung, H LeeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.